Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Buscail

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Clinical Endocrinology|January 13, 2006
Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumoursDelphine Vezzosi, Michèle Bouisson, Ghislaine Escourrou, et al.
Human Gene Therapy|March 28, 2009
let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progressionJérôme Torrisani, Barbara Bournet, Maël Chalret du Rieu, et al.
Human Gene Therapy|October 13, 2005
Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cellsNicolas Carrere, Fabienne Vernejoul, Anny Souque, et al.
Human Gene Therapy|April 10, 2026
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer CellsNikolaos Kontopoulos, Noémie Delenclos, Laetitia Ligat, et al.
Plos One|February 6, 2013
The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic toolYannick Delpu, Hubert Lulka, Flavie Sicard, et al.
Oncogene|September 5, 2003
High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptorCéline Galés, Didier Sanchez, Marc Poirot, et al.
Endocrinology|March 8, 2008
Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modificationsJérôme Torrisani, Naïma Hanoun, Henrik Laurell, et al.
Case Reports in Dermatology|April 18, 2022
Severe Vulvar and Perianal Crohn's Disease: A Case Report and Review of the LiteratureGuillaume Le Cosquer, Alexis Barranca, Louise Lapotre, et al.
Molecular Therapy. Nucleic Acids|July 24, 2019
Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic CancerZamira Vanessa Diaz-Riascos, Mireia M Ginesta, Joan Fabregat, et al.
International Journal of Molecular Sciences|April 16, 2020
Circulating Tumor Cell Clusters: United We Stand Divided We FallSamuel Amintas, Aurélie Bedel, François Moreau-Gaudry, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Clinical Endocrinology|January 13, 2006
Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumoursDelphine Vezzosi, Michèle Bouisson, Ghislaine Escourrou, et al.
Human Gene Therapy|March 28, 2009
let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progressionJérôme Torrisani, Barbara Bournet, Maël Chalret du Rieu, et al.
Human Gene Therapy|October 13, 2005
Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cellsNicolas Carrere, Fabienne Vernejoul, Anny Souque, et al.
Human Gene Therapy|April 10, 2026
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer CellsNikolaos Kontopoulos, Noémie Delenclos, Laetitia Ligat, et al.
Plos One|February 6, 2013
The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic toolYannick Delpu, Hubert Lulka, Flavie Sicard, et al.
Oncogene|September 5, 2003
High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptorCéline Galés, Didier Sanchez, Marc Poirot, et al.
Endocrinology|March 8, 2008
Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modificationsJérôme Torrisani, Naïma Hanoun, Henrik Laurell, et al.
Case Reports in Dermatology|April 18, 2022
Severe Vulvar and Perianal Crohn's Disease: A Case Report and Review of the LiteratureGuillaume Le Cosquer, Alexis Barranca, Louise Lapotre, et al.
Molecular Therapy. Nucleic Acids|July 24, 2019
Expression and Role of MicroRNAs from the miR-200 Family in the Tumor Formation and Metastatic Propensity of Pancreatic CancerZamira Vanessa Diaz-Riascos, Mireia M Ginesta, Joan Fabregat, et al.
International Journal of Molecular Sciences|April 16, 2020
Circulating Tumor Cell Clusters: United We Stand Divided We FallSamuel Amintas, Aurélie Bedel, François Moreau-Gaudry, et al.
Pageof 12